American Bio Medica Corporation
ABMC · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $913 | $2,218 | $4,147 | $3,655 |
| % Growth | -58.8% | -46.5% | 13.5% | – |
| Cost of Goods Sold | $1,106 | $1,670 | $2,909 | $2,471 |
| Gross Profit | -$193 | $548 | $1,238 | $1,184 |
| % Margin | -21.1% | 24.7% | 29.9% | 32.4% |
| R&D Expenses | $85 | $85 | $90 | $82 |
| G&A Expenses | $917 | $1,338 | $1,276 | $1,236 |
| SG&A Expenses | $1,054 | $1,642 | $1,769 | $1,695 |
| Sales & Mktg Exp. | $137 | $304 | $493 | $459 |
| Other Operating Expenses | -$90 | $0 | $0 | $0 |
| Operating Expenses | $1,049 | $1,727 | $1,859 | $1,777 |
| Operating Income | -$1,242 | -$1,179 | -$621 | -$593 |
| % Margin | -136% | -53.2% | -15% | -16.2% |
| Other Income/Exp. Net | -$166 | $718 | -$173 | -$93 |
| Pre-Tax Income | -$1,408 | -$461 | -$794 | -$686 |
| Tax Expense | $2 | $2 | $2 | -$5 |
| Net Income | -$1,410 | -$463 | -$796 | -$681 |
| % Margin | -154.4% | -20.9% | -19.2% | -18.6% |
| EPS | -0.029 | -0.011 | -0.022 | -0.021 |
| % Growth | -172.2% | 51.8% | -7.2% | – |
| EPS Diluted | -0.029 | -0.011 | -0.022 | -0.021 |
| Weighted Avg Shares Out | 48,018 | 42,761 | 35,558 | 32,527 |
| Weighted Avg Shares Out Dil | 48,018 | 42,761 | 35,558 | 32,527 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $0 | $0 | $0 |
| Interest Expense | $194 | $194 | $175 | $265 |
| Depreciation & Amortization | $51 | $68 | $79 | $81 |
| EBITDA | -$1,163 | -$199 | -$540 | -$340 |
| % Margin | -127.4% | -9% | -13% | -9.3% |